Activity, safety and circulating tumour DNA (ctDNA) dynamics of paradox breaker BRAF inhibitor PLX8394 in patients with advanced cancer

被引：2

作者：

Gouda, M. A. ^{[1
]}

Sherman, E. J. ^{[2
]}

Gilcrease, G. W. ^{[3
]}

Vaishampayan, U. N. ^{[4
]}

Parikh, A. ^{[5
]}

Feun, L. ^{[6
]}

Kummar, S. ^{[7
]}

Huang, H. ^{[1
]}

Zhang, C. ^{[8
]}

Severson, P. ^{[8
]}

Inokuchi, K. ^{[8
]}

Silverman, M. ^{[8
]}

Bollag, G. ^{[8
]}

Janku, F. ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Houston, TX 77030 USA

[2] Mem Sloan Kettering Canc Ctr, Med Oncol, 1275 York Ave, New York, NY 10021 USA

[3] Huntsman Canc Inst, Med Oncol, Salt Lake City, UT USA

[4] Univ Michigan, Div Hematol Oncol, Michigan Med, Ann Arbor, MI 48109 USA

[5] Massachusetts Gen Hosp, Med Oncol, Boston, MA 02114 USA

[6] Sylvester Comprehens Canc Ctr, Hematol Oncol, Miami, FL USA

[7] Stanford Univ, Med Oncol, Palo Alto, CA 94304 USA

[8] Plexxikon Inc, Berkeley, CA USA

来源：

ANNALS OF ONCOLOGY | 2020年 / 31卷

关键词：

D O I：

10.1016/j.annonc.2020.08.643

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

529MO

引用

页码：S465 / S465

页数：1

共 50 条

[1] RAF 'Paradox Breaker' Inhibitor, PLX8394, Enhances Inflammation And Apoptosis In Murine Hypertension In Vivo
Cooper, Susanna T.
Malone, Giles O.
Haines, Zoe H.
Meijles, Daniel N.
CIRCULATION RESEARCH, 2022, 131
[2] THE RAF 'PARADOX BREAKER' INHIBITOR, PLX8394, ACTIVATES ERK1/2 IN ENDOTHELIAL CELLS AND PROMOTES CARDIAC REMODELLING
Cooper, Susanna
Cull, Josh
Clerk, Angela
Meijles, Daniel
HEART, 2021, 107 : A174 - A174
[3] SAFETY AND EFFICACY OF BRAF INHIBITOR PLIXORAFENIB (FORE8394; PLX8394) IN CHILDREN AND ADULTS WITH RECURRENT, BRAF-ALTERED PRIMARY CENTRAL NERVOUS SYSTEM TUMORS (PCNST)
de la Fuente, Macarena
Butowski, Nicholas A.
Taylor, Jennie
Yaeger, Rona
Tsai, Frank Y-C
Janku, Filip
Allen, Carl E.
Ammakkanavar, Natraj
Michelson, Glenn
Jiang, Ping
Samara, Emil
Paz, Michael
Tussay-Lindenberg, Alexia
Wang, Kongming
Shepherd, Stacie P.
Kline, Irina
Sherman, Eric
Rodon, Jordi
NEURO-ONCOLOGY, 2024, 26
[4] BRAF paradox breakers PLX8394, PLX7904 are more effective against BRAFV600E CRC cells compared with the BRAF inhibitor PLX4720 and shown by detailed pathway analysis
Koumaki, Kassandra
Kontogianni, Georgia
Kosmidou, Vivian
Pahitsa, Fani
Kritsi, Eftichia
Zervou, Maria
Chatziioannou, Aristotelis
Souliotis, Vassilis L.
Papadodima, Olga
Pintzas, Alexander
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2021, 1867 (04):
[5] The dynamics of circulating tumour DNA (ctDNA) during treatment reflects tumour response in advanced melanoma patients
Di Nardo, Lucia
Del Regno, Laura
Di Stefani, Alessandro
Mannino, Maria
Fossati, Barbara
Catapano, Silvia
Quattrini, Laura
Pellegrini, Cristina
Cortellini, Alessio
Parisi, Alessandro
Capoluongo, Ettore
Autilio, Chiara
Fargnoli, Maria Concetta
Peris, Ketty
EXPERIMENTAL DERMATOLOGY, 2023, 32 (10) : 1785 - 1793
[6] Monitoring tumour resistance to the BRAF inhibitor combination regimen in colorectal cancer patients via circulating tumour DNA
Ye, Liu-Fang
Huang, Zi-Yao
Chen, Xiao-Xi
Chen, Zhi-Gang
Wu, Si-Xian
Ren, Chao
Hu, Ming-Tao
Bao, Hua
Jin, Ying
Wang, Feng
Wang, Feng-Hua
Du, Zi-Ming
Wu, Xue
Ju, Huai-Qiang
Shao, Yang
Li, Yu-Hong
Xu, Rui-Hua
Wang, De-Shen
DRUG RESISTANCE UPDATES, 2022, 65
[7] KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer
Sclafani, Francesco
Chau, Ian
Cunningham, David
Hahne, Jens C.
Vlachogiannis, George
Eltahir, Zakaria
Lampis, Andrea
Braconi, Chiara
Kalaitzaki, Eleftheria
De Castro, David Gonzalez
Wotherspoon, Andrew
Capdevila, Jaume
Glimelius, Bengt
Tarazona, Noelia
Begum, Ruwaida
Lote, Hazel
Wilson, Sanna Hulkki
Mentrasti, Giulia
Brown, Gina
Tait, Diana
Oates, Jacqueline
Valeri, Nicola
SCIENTIFIC REPORTS, 2018, 8
[8] KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer
Francesco Sclafani
Ian Chau
David Cunningham
Jens C. Hahne
George Vlachogiannis
Zakaria Eltahir
Andrea Lampis
Chiara Braconi
Eleftheria Kalaitzaki
David Gonzalez De Castro
Andrew Wotherspoon
Jaume Capdevila
Bengt Glimelius
Noelia Tarazona
Ruwaida Begum
Hazel Lote
Sanna Hulkki Wilson
Giulia Mentrasti
Gina Brown
Diana Tait
Jacqueline Oates
Nicola Valeri
Scientific Reports, 8
[9] Circulating tumor DNA (ctDNA) dynamics in response to checkpoint inhibitor immunotherapy in colorectal cancer
Patell, Kanchi
Kurian, Matthew
Booker, Benjamin
Chung, Michelle
Bennett, Alexis
Bajor, David L.
Mohamed, A. M. R.
Mahipal, Amit
Chakrabarti, Sakti
Selfridge, J. Eva
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[10] Use of Circulating Tumour DNA (ctDNA) for Measurement of Therapy Predictive Biomarkers in Patients with Cancer
Duffy, Michael J.
Crown, John
JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (01):

← 1 2 3 4 5 →